Comparison 4. High rifampicin dose versus standard rifampicin dose.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Failure | 1 | 50 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.0 [0.0, 0.0] |
2 Resolution of fever within 48 hours | 1 | 50 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.03 [0.77, 1.38] |
3 Serious adverse events | 1 | 50 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.0 [0.0, 0.0] |